Targeted Radiopharmaceutical Market, By Product Type (Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals), By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
ANV5908
|
Published Date
August 2026
|
Pages
305
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Targeted Radiopharmaceutical Market size was valued at US$ 5,108.7 Million in 2025, expanding at a CAGR of 10.9% from 2026 to 2033.
Targeted radiopharmaceuticals represent a special category of precision medicines that involve attaching a radioactive isotope to molecules that specifically target certain tissues. The targeted radiopharmaceuticals market consists of diagnostic PET and SPECT agents, therapeutic radioligands, radionuclide precursors, generators, radiolabeling equipment, and contract manufacturing and control services. The main area of application is oncology, primarily prostate cancer and neuroendocrine tumors, but there are also significant applications in cardiology and neurology. At the same time, the short half-lives of many isotopes mean that their production, sterile storage, transportation, and medical equipment are important aspects of the supply chain. In 2025, U.S. hospitals used approximately 40,000 doses of the isotope Mo-99 every day in diagnostic procedures. Therefore, the availability of isotopes plays an essential role in targeted radiopharmaceuticals, complementing the need to develop new molecules and cell targets, and is a major competitive advantage.
Targeted Radiopharmaceutical Market- Market Dynamics
Theranostics Is Reshaping Precision Treatment Pathways
The combination of molecular imaging and targeted therapy is leading to a more integrated approach to precision oncology. Theranostic platforms are designed to utilize diagnostic imaging to identify patients with tumor expression of a given target and then treat those patients with a theranostic agent that specifically targets the same receptor. As such, the development of these approaches is driving need for companion diagnostics, isotope supply chains, radiochemistry infrastructure, dosimetry, and specialized treatment centers. In March 2025, the FDA approved Pluvicto for use in patients with PSMA-positive metastatic castration-resistant prostate cancer who had received an androgen-receptor pathway inhibitor, and the PSMAfore trial saw a 59% reduction in the risk of radiographic progression or death from the control treatment, further bolstering the case for earlier molecularly guided radioligand treatment and supporting the growth of the theranostics market.
Targeted Radiopharmaceutical Market- Geographical Insights
North America is the leading radiopharmaceuticals market due to the strong network of pharmaceutical companies, biotech developers, academic nuclear-medicine centers, national isotope programs, and specialized manufacturing facilities. The radiopharmaceuticals market is highly dependent on the stable supply of short-lived isotopes, offers limited scope for delays, disruptions, and inventory management errors. Policymakers and pharmaceutical companies throughout the region are prioritizing the development of domestic isotope production capabilities and radioligand manufacturing to ensure an uninterrupted supply of medical isotopes. As of 2025, there are 40000 Mo-99 diagnostic doses produced daily in the US, which underlines the level of nuclear medicine adoption in the region. North America is therefore strongly positioned to benefit from the worldwide in nuclear medicine while also being the driving force behind the development of novel therapeutics.
Europe\'s targeted radiopharmaceutical landscape is supported by the existing nuclear-medicine infrastructure, pharma expertise, research facilities, and regulations. The region also lacks centralized control over radiopharmaceutical production and distribution, meaning the supply chain is of utmost importance. Moreover, time constraints for isotope use require efficient distribution networks. For example, in April 2025, the European Medicines Agency and Heads of Medicines Agencies released recommendations concerning the radiopharmaceutical supply situation in the EU. This shows that the region has the best conditions to manage and respond to such crises because of the harmonization of regulations, high pharma production capabilities, and proactive measures at multiple levels.
Targeted Radiopharmaceutical Market- Competitive Landscape:
Competition in targeted radiopharmaceuticals market is now focusing on broader areas from target discovery, access to radionuclides, radiochemistry, manufacturing, and clinical development to distribution. Thus, Novartis has developed a comprehensive radioligand platform, while competitors, including Bayer, Lantheus, Curium, and new biotech companies, are positioning themselves to provide diverse products and technologies in therapeutics, diagnostics, manufacturing, and specific areas of radiochemistry. Moreover, the overall capacity of production is critical, as radiopharmaceutical requires a stable and reliable supply chain that produces medicines with a short shelf life. Therefore, Novartis opened its third U.S. radioligand manufacturing facility in the Los Angeles area in November 2025. Hence, the ability to deliver complex radioligands to the clinic reliably allows Novartis to differentiate itself from competitors and provide a consistent supply of medicinal products for clinical partners and patients worldwide.
Recent Developments:
- In March 2025, Novartis: The U.S. FDA expanded the indication of Pluvicto for patients with PSMA-positive metastatic castration-resistant prostate cancer who had received androgen-receptor pathway inhibitor therapy and were treatment-naive in the second-line setting. The new indication moved radioligand therapy to an earlier treatment paradigm and extended the indication to a broader patient population.
- In November 2025, Novartis opened a new 10,000-square-foot radioligand manufacturing facility in Carlsbad, California. This new U.S. radioligand production site is the company’s third in the U.S. The new facility will help meet the needs of manufacturing these complex therapies while supporting the time-sensitive nature of radiolabeled compounds.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL TARGETED RADIOPHARMACEUTICAL MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Novartis AG
- Lantheus Holdings, Inc.
- Curium Pharma
- GE HealthCare
- Bayer AG
- AstraZeneca plc
- Eli Lilly and Company
- Bristol Myers Squibb
- ITM Isotope Technologies Munich SE
- Telix Pharmaceuticals Limited
- Bracco Imaging S.p.A.
- Clarity Pharmaceuticals Ltd.
- Eckert & Ziegler SE
- Actinium Pharmaceuticals, Inc.
- Evergreen Theragnostics, Inc.
- Siemens Healthineers AG
- Cardinal Health, Inc.
- Boehringer Ingelheim International GmbH
- Perspective Therapeutics, Inc.
- RadioMedix, Inc.
- NorthStar Medical Radioisotopes
- Others
GLOBAL TARGETED RADIOPHARMACEUTICAL MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033
- Diagnostic Radiopharmaceuticals
- PET Radiopharmaceuticals
- SPECT Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals
- Beta-Emitting
- Alpha-Emitting
- Others
GLOBAL TARGETED RADIOPHARMACEUTICAL MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Oncology
- Cardiology
- Neurology
- Endocrinology / Thyroid
- Others
GLOBAL TARGETED RADIOPHARMACEUTICAL MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals & Clinics
- Diagnostic Imaging Centers
- Nuclear Medicine Centers
- Cancer Treatment Centers
- Academic & Research Institutes
- Others
GLOBAL TARGETED RADIOPHARMACEUTICAL MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
TABLE OF CONTENTS
1. Targeted Radiopharmaceutical Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Targeted Radiopharmaceutical Market Snippet by Product Type
2.1.2. Targeted Radiopharmaceutical Market Snippet by Application
2.1.3. Targeted Radiopharmaceutical Market Snippet by End User
2.1.4. Targeted Radiopharmaceutical Market Snippet by Country
2.1.5. Targeted Radiopharmaceutical Market Snippet by Region
2.2. Competitive Insights
3. Targeted Radiopharmaceutical Key Market Trends
3.1. Targeted Radiopharmaceutical Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Targeted Radiopharmaceutical Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Targeted Radiopharmaceutical Market Opportunities
3.4. Targeted Radiopharmaceutical Market Future Trends
4. Targeted Radiopharmaceutical Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Targeted Radiopharmaceutical Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Targeted Radiopharmaceutical Market Landscape
6.1. Targeted Radiopharmaceutical Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Targeted Radiopharmaceutical Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
7.1.2. Diagnostic Radiopharmaceuticals
7.1.2.1. PET Radiopharmaceuticals
7.1.2.2. SPECT Radiopharmaceuticals
7.1.3. Therapeutic Radiopharmaceuticals
7.1.3.1. Beta-Emitting
7.1.3.2. Alpha-Emitting
7.1.3.3. Others
8. Targeted Radiopharmaceutical Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
8.1.2. Oncology
8.1.3. Cardiology
8.1.4. Neurology
8.1.5. Endocrinology / Thyroid
8.1.6. Others
9. Targeted Radiopharmaceutical Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
9.1.2. Hospitals & Clinics
9.1.3. Diagnostic Imaging Centers
9.1.4. Nuclear Medicine Centers
9.1.5. Cancer Treatment Centers
9.1.6. Academic & Research Institutes
9.1.7. Others
10. Targeted Radiopharmaceutical Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
10.2. North America
10.2.1. Overview
10.2.2. Targeted Radiopharmaceutical Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Targeted Radiopharmaceutical Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.16. Denmark
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.16.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.17. Rest of Europe
10.3.17.1. Overview
10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Targeted Radiopharmaceutical Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.15. Taiwan
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.15.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.16. Vietnam
10.4.16.1. Overview
10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.16.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.17. Rest of APAC
10.4.17.1. Overview
10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Targeted Radiopharmaceutical Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Targeted Radiopharmaceutical Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.13. Iran
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.13.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.14. Qatar
10.6.14.1. Overview
10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.14.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.15. Rest of MEA
10.6.15.1. Overview
10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11. Key Vendor Analysis- Targeted Radiopharmaceutical Industry
11.1. Competitive Benchmarking
11.1.1. Competitive Dashboard
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Novartis AG
11.2.2. Lantheus Holdings, Inc.
11.2.3. Curium Pharma
11.2.4. GE HealthCare
11.2.5. Bayer AG
11.2.6. AstraZeneca plc
11.2.7. Eli Lilly and Company
11.2.8. Bristol Myers Squibb
11.2.9. ITM Isotope Technologies Munich SE
11.2.10. Telix Pharmaceuticals Limited
11.2.11. Bracco Imaging S.p.A.
11.2.12. Clarity Pharmaceuticals Ltd.
11.2.13. Eckert & Ziegler SE
11.2.14. Actinium Pharmaceuticals, Inc.
11.2.15. Evergreen Theragnostics, Inc.
11.2.16. Siemens Healthineers AG
11.2.17. Cardinal Health, Inc.
11.2.18. Boehringer Ingelheim International GmbH
11.2.19. Perspective Therapeutics, Inc.
11.2.20. RadioMedix, Inc.
11.2.21. NorthStar Medical Radioisotopes
11.2.22. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL TARGETED RADIOPHARMACEUTICAL MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Novartis AG
- Lantheus Holdings, Inc.
- Curium Pharma
- GE HealthCare
- Bayer AG
- AstraZeneca plc
- Eli Lilly and Company
- Bristol Myers Squibb
- ITM Isotope Technologies Munich SE
- Telix Pharmaceuticals Limited
- Bracco Imaging S.p.A.
- Clarity Pharmaceuticals Ltd.
- Eckert & Ziegler SE
- Actinium Pharmaceuticals, Inc.
- Evergreen Theragnostics, Inc.
- Siemens Healthineers AG
- Cardinal Health, Inc.
- Boehringer Ingelheim International GmbH
- Perspective Therapeutics, Inc.
- RadioMedix, Inc.
- NorthStar Medical Radioisotopes
- Others
GLOBAL TARGETED RADIOPHARMACEUTICAL MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033
- Diagnostic Radiopharmaceuticals
- PET Radiopharmaceuticals
- SPECT Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals
- Beta-Emitting
- Alpha-Emitting
- Others
GLOBAL TARGETED RADIOPHARMACEUTICAL MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Oncology
- Cardiology
- Neurology
- Endocrinology / Thyroid
- Others
GLOBAL TARGETED RADIOPHARMACEUTICAL MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals & Clinics
- Diagnostic Imaging Centers
- Nuclear Medicine Centers
- Cancer Treatment Centers
- Academic & Research Institutes
- Others
GLOBAL TARGETED RADIOPHARMACEUTICAL MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
